A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro

References to this release by other works.

Read more about quality, completeness, and caveats in the fatcat guide.

Showing 0 references (in 60ms)
No References Found
JSON

A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro release_abh72ntsmjdhfhfctic2kg5ixe